PCSK9 inhibitors
TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?
Phil Taylor
Amgen, cardiovascular disease, cholesterol, gene silencing, inclisiran, PCSK9 inhibitors, Praluent, Regeneron, Repatha, RNA interference, Sanofi, The Medicines Company
0 Comment
X
TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?
https://pharmaphorum.com/news/tmcs-inclisiran-impresses-at-esc-but-will-it-surpass-pcsk9-rivals/